mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes-Reference-Cited by-同舟云学术

mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes

Published:2022-06 Issue:6 Volume:3 Page:100653
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Zimmerman Ofer,Altman Doss Alexa Michelle,Kaplonek Paulina,Liang Chieh-Yu,VanBlargan Laura A.,Chen Rita E.,Monroy Jennifer Marie,Wedner H. James,Kulczycki Anthony,Mantia Tarisa L.,O’Shaughnessy Caitlin C.,Davis-Adams Hannah G.,Bertera Harry L.,Adams Lucas J.,Raju Saravanan,Zhao Fang R.,Rigell Christopher J.,Dy Tiffany Biason,Kau Andrew L.,Ren Zhen,Turner Jackson S.,O’Halloran Jane A.,Presti Rachel M.,Fremont Daved H.,Kendall Peggy L.,Ellebedy Ali H.,Alter Galit,Diamond Michael S.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference53 articles.

1. International consensus document (ICON): common variable immunodeficiency disorders;Bonilla;J. Allergy Clin. Immunol. Pract.,2016

2. International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity;Picard;J. Clin. Immunol.,2018

3. Morbidity and mortality in common variable immune deficiency over 4 decades;Resnick;Blood,2012

4. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID);Hammarstrom;Clin. Exp. Immunol.,2001

5. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications;Hermaszewski;Q. J. Med.,1993

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity;Vaccines;2024-06-18

2. Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program;Frontiers in Immunology;2024-04-18

3. IVT-mRNA reprogramming of myeloid cells for cancer immunotherapy;Advances in Pharmacology;2024

4. Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic;Journal of Clinical Immunology;2023-12-22

5. SARS-CoV-2 vaccination in primary antibody deficiencies: an overview on efficacy, immunogenicity, durability of immune response and safety;Current Opinion in Allergy & Clinical Immunology;2023-11-14